Perceived autonomy support in individuals with Parkinson’s disease requiring emergency care: a cross-sectional pilot study
-
Published:2024-08-15
Issue:1
Volume:6
Page:
-
ISSN:2524-3489
-
Container-title:Neurological Research and Practice
-
language:en
-
Short-container-title:Neurol. Res. Pract.
Author:
Florijn Barend W.ORCID, van Zwet Erik W., Kaptein Ad. A., van der Plas Anne A.
Abstract
Abstract
Background
Individuals with Parkinson’s disease (PD) report a diminished perceived functional autonomy as their condition progresses. For those seeking emergency care, it is unknown whether the patient-physician relationship is instrumental in respecting patient autonomy. This study evaluated patient autonomy ideals in individuals with PD requiring emergency care and the perceived support for autonomy from emergency department physicians.
Method
Individuals with PD (n = 36, average age 78.1 years) were surveyed using the Ideal Patient Autonomy questionnaire (IPA) and the Health Care Climate Questionnaire (HCCQ). A multivariable regression analysis assessed whether patients’ Hoehn and Yahr stage and IPA questionnaire results predicted HCCQ items.
Results
The IPA questionnaire revealed that individuals with PD in need of emergency care emphasize the significance of medical expertise (IPA ‘doctor should decide’ theme 0.71) in decision-making and their desire to be fully informed about all potential risks (IPA ‘obligatory risk information’ theme 0.71). The average HCCQ values showed a decreasing trend across Hoehn and Yahr stages 1 to 5: 6.19, 6.03, 5.83, 5.80, and 5.23, respectively. HY scale values also influenced HCCQ items related to the physician’s role.
Conclusion
In our cohort, individuals with Parkinson’s disease tend to rely on medical expertise for decision-making and prioritize complete risk information during emergency care. However, this autonomy support diminishes as functional disability levels increase.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Ascherio, A., & Schwarzschild, M. A. (2016). The epidemiology of Parkinson’s disease: Risk factors and prevention. Lancet Neurology, 15(12), 1257–1272. https://doi.org/10.1016/s1474-4422(16)30230-7 2. Dorsey, E. R., & Bloem, B. R. (2018). The Parkinson pandemic—A call to action. JAMA Neurology, 75(1), 9–10. https://doi.org/10.1001/jamaneurol.2017.3299 3. Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson’s disease. Lancet, 397(10291), 2284–2303. https://doi.org/10.1016/s0140-6736(21)00218-x 4. Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., Ffytche, D. H., Weintraub, D., & Ballard, C. (2017). Cognitive decline in Parkinson disease. Nature Reviews Neurology, 13(4), 217–231. https://doi.org/10.1038/nrneurol.2017.27 5. D’Iorio, A., Vitale, C., Piscopo, F., Baiano, C., Falanga, A. P., Longo, K., Amboni, M., Barone, P., & Santangelo, G. (2017). Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson’s disease. Parkinsonism & Related Disorders, 43, 114–117. https://doi.org/10.1016/j.parkreldis.2017.08.003
|
|